Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

Reply to: Deprescribing Attitudes of Older Adults Receiving Medication Management Support from Home-Based Nurses.

Reeve E, Low LF, Hilmer SN.

J Am Geriatr Soc. 2019 Jun 13. doi: 10.1111/jgs.16012. [Epub ahead of print] No abstract available.

PMID:
31190352
2.

Going Beyond the Guidelines in Individualising the Use of Antihypertensive Drugs in Older Patients.

Scott IA, Hilmer SN, Le Couteur DG.

Drugs Aging. 2019 Jun 7. doi: 10.1007/s40266-019-00683-8. [Epub ahead of print]

PMID:
31175614
3.

Biology of frailty: Implications for clinical pharmacology and drug therapy in frail older people.

Hilmer SN, Wu H, Zhang M.

Mech Ageing Dev. 2019 May 22;181:22-28. doi: 10.1016/j.mad.2019.111119. [Epub ahead of print] Review.

PMID:
31125572
4.

Health professionals' and researchers' opinions on conducting clinical deprescribing trials.

Clough AJ, Hilmer SN, Kouladjian-O'Donnell L, Naismith SL, Gnjidic D.

Pharmacol Res Perspect. 2019 Apr 25;7(3):e00476. doi: 10.1002/prp2.476. eCollection 2019 Jun.

5.

The impact of frailty on prolonged hospitalization and mortality in elderly inpatients in Vietnam: a comparison between the frailty phenotype and the Reported Edmonton Frail Scale.

Nguyen AT, Nguyen TX, Nguyen TN, Nguyen THT, Pham T, Cumming R, Hilmer SN, Vu HTT.

Clin Interv Aging. 2019 Feb 20;14:381-388. doi: 10.2147/CIA.S189122. eCollection 2019.

6.

Integration of an electronic Drug Burden Index risk assessment tool into Home Medicines Reviews: deprescribing anticholinergic and sedative medications.

Kouladjian O'Donnell L, Gnjidic D, Chen TF, Hilmer SN.

Ther Adv Drug Saf. 2019 Mar 5;10:2042098619832471. doi: 10.1177/2042098619832471. eCollection 2019.

7.

Examining the Risks of Major Bleeding Events in Older People Using Antithrombotics.

Nishtala PS, Jamieson HA, Hanger HC, Chyou TY, Hilmer SN.

Cardiovasc Drugs Ther. 2019 Jun;33(3):323-329. doi: 10.1007/s10557-019-06867-z.

8.

Patterns of high-risk prescribing and other factors in relation to receipt of a home medicines review: a prospective cohort investigation among adults aged 45 years and over in Australia.

Du W, Gnjidic D, Pearson SA, Hilmer SN, McLachlan AJ, Blyth F, Viney R, Joshy G, Day C, Banks E.

BMJ Open. 2019 Feb 15;9(2):e027305. doi: 10.1136/bmjopen-2018-027305.

9.

Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary.

Reeve E, Farrell B, Thompson W, Herrmann N, Sketris I, Magin PJ, Chenoweth L, Gorman M, Quirke L, Bethune G, Hilmer SN.

Med J Aust. 2019 Mar;210(4):174-179. doi: 10.5694/mja2.50015. Epub 2019 Feb 16.

PMID:
30771226
10.

Attitudes of Older Adults and Caregivers in Australia toward Deprescribing.

Reeve E, Low LF, Hilmer SN.

J Am Geriatr Soc. 2019 Jun;67(6):1204-1210. doi: 10.1111/jgs.15804. Epub 2019 Feb 13.

PMID:
30756387
11.

Long-term exposure to anticholinergic and sedative medications and cognitive and physical function in later life.

Wouters H, Hilmer SN, Gnjidic D, Van Campen JP, Teichert M, Van Der Meer HG, Schaap LA, Huisman M, Comijs HC, Denig P, Lamoth CJ, Taxis K.

J Gerontol A Biol Sci Med Sci. 2019 Jan 21. doi: 10.1093/gerona/glz019. [Epub ahead of print]

PMID:
30668633
12.

IUPHAR International geriatric clinical pharmacology curriculum for medical students.

Kashyap M, Thuermann P, Le Couteur DG, Abernethy DR, Hilmer SN.

Pharmacol Res. 2019 Mar;141:611-615. doi: 10.1016/j.phrs.2019.01.032. Epub 2019 Jan 17. No abstract available.

PMID:
30660820
13.

Approaches to Deprescribing Psychotropic Medications for Changed Behaviours in Long-Term Care Residents Living with Dementia.

Harrison SL, Cations M, Jessop T, Hilmer SN, Sawan M, Brodaty H.

Drugs Aging. 2019 Feb;36(2):125-136. doi: 10.1007/s40266-018-0623-6. Review.

PMID:
30535930
14.

Assessment of Attitudes Toward Deprescribing in Older Medicare Beneficiaries in the United States.

Reeve E, Wolff JL, Skehan M, Bayliss EA, Hilmer SN, Boyd CM.

JAMA Intern Med. 2018 Dec 1;178(12):1673-1680. doi: 10.1001/jamainternmed.2018.4720.

PMID:
30326004
15.

Calculating and using the drug burden index score in research and practice.

Hilmer SN.

Expert Rev Clin Pharmacol. 2018 Nov;11(11):1053-1055. doi: 10.1080/17512433.2018.1528145. Epub 2018 Sep 29. No abstract available.

PMID:
30269609
16.

Current approaches to the pharmacological treatment of Alzheimer's disease.

Tan EC, Hilmer SN, Garcia-Ptacek S, Bell JS.

Aust J Gen Pract. 2018 Sep;47(9):586-592.

PMID:
30244564
17.

Deprescribing: the emerging evidence for and the practice of the 'geriatrician's salute'.

Hilmer SN, Gnjidic D.

Age Ageing. 2018 Sep 1;47(5):638-640. doi: 10.1093/ageing/afy014.

PMID:
30165501
18.

Corrigendum to: The Effect of Aging on Acetaminophen Pharmacokinetics, Toxicity and Nrf2 in Fischer 344 Rats.

Mach J, Huizer-Pajkos A, Cogger VC, McKenzie C, Le Couteur DG, Jones BE, de Cabo R, Hilmer SN.

J Gerontol A Biol Sci Med Sci. 2019 Feb 15;74(3):332. doi: 10.1093/gerona/gly160. No abstract available.

19.

Drug Burden Index and Its Association With Hip Fracture Among Older Adults: A National Population-Based Study.

Jamieson HA, Nishtala PS, Scrase R, Deely JM, Abey-Nesbit R, Hilmer SN, Abernethy DR, Berry SD, Mor V, Lacey CJ, Schluter PJ.

J Gerontol A Biol Sci Med Sci. 2019 Jun 18;74(7):1127-1133. doi: 10.1093/gerona/gly176.

PMID:
30084928
20.

Development and pilot testing of the revised Patients' Attitudes Towards Deprescribing questionnaire for people with cognitive impairment.

Reeve E, Anthony AC, Kouladjian O'Donnell L, Low LF, Ogle SJ, Glendenning JE, Lorang CE, Hilmer SN.

Australas J Ageing. 2018 Dec;37(4):E150-E154. doi: 10.1111/ajag.12576. Epub 2018 Aug 6.

PMID:
30084180
21.

Organisational culture must be addressed to reduce psychotropic prescribing in Residential Aged Care Facilities.

Sawan M, Chen TF, Jeon YH, Hilmer SN.

Aust N Z J Psychiatry. 2019 Jan;53(1):87. doi: 10.1177/0004867418781490. Epub 2018 Jun 18. No abstract available.

PMID:
29911394
22.

Development and validation of the Medication Regimen Simplification Guide for Residential Aged CarE (MRS GRACE).

Chen EY, Sluggett JK, Ilomäki J, Hilmer SN, Corlis M, Picton LJ, Dean L, Alderman CP, Farinola N, Gailer J, Grigson J, Kellie AR, Putsey PJ, Yu S, Bell JS.

Clin Interv Aging. 2018 May 18;13:975-986. doi: 10.2147/CIA.S158417. eCollection 2018.

23.

Interventions to Reduce Antipsychotic Prescribing in Nursing Homes Must Cross Healthcare Silos.

Sawan M, Chen T, Jeon YH, Hilmer SN.

J Am Geriatr Soc. 2018 Jul;66(6):1235-1236. doi: 10.1111/jgs.15349. Epub 2018 May 2. No abstract available.

PMID:
29719040
24.

Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients.

Ng BJ, Le Couteur DG, Hilmer SN.

Drugs Aging. 2018 Jun;35(6):493-521. doi: 10.1007/s40266-018-0544-4. Review.

PMID:
29705831
25.

Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis.

Kongpakwattana K, Sawangjit R, Tawankanjanachot I, Bell JS, Hilmer SN, Chaiyakunapruk N.

Br J Clin Pharmacol. 2018 Jul;84(7):1445-1456. doi: 10.1111/bcp.13604. Epub 2018 May 14. Review.

PMID:
29637593
26.

Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria.

Motter FR, Fritzen JS, Hilmer SN, Paniz ÉV, Paniz VMV.

Eur J Clin Pharmacol. 2018 Jun;74(6):679-700. doi: 10.1007/s00228-018-2446-0. Epub 2018 Mar 27. Review.

PMID:
29589066
27.

Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials.

Thillainadesan J, Gnjidic D, Green S, Hilmer SN.

Drugs Aging. 2018 Apr;35(4):303-319. doi: 10.1007/s40266-018-0536-4. Review.

PMID:
29541966
28.

Psychotropic medications in older people in residential care facilities and associations with quality of life: a cross-sectional study.

Harrison SL, Bradley C, Milte R, Liu E, Kouladjian O'Donnell L, Hilmer SN, Crotty M.

BMC Geriatr. 2018 Feb 26;18(1):60. doi: 10.1186/s12877-018-0752-0.

29.

Development and validation of an instrument for measuring the burden of medicine on functioning and well-being: the Medication-Related Burden Quality of Life (MRB-QoL) tool.

Mohammed MA, Moles RJ, Hilmer SN, Kouladjian O'Donnel L, Chen TF.

BMJ Open. 2018 Jan 11;8(1):e018880. doi: 10.1136/bmjopen-2017-018880.

30.

SImplification of Medications Prescribed to Long-tErm care Residents (SIMPLER): study protocol for a cluster randomised controlled trial.

Sluggett JK, Chen EYH, Ilomäki J, Corlis M, Hilmer SN, Van Emden J, Ooi CE, Nguyen KH, Comans T, Hogan M, Caporale T, Edwards S, Quirke L, Patching A, Bell JS.

Trials. 2018 Jan 12;19(1):37. doi: 10.1186/s13063-017-2417-2.

31.

Costs of potentially inappropriate medication use in residential aged care facilities.

Harrison SL, Kouladjian O'Donnell L, Milte R, Dyer SM, Gnanamanickam ES, Bradley C, Liu E, Hilmer SN, Crotty M.

BMC Geriatr. 2018 Jan 11;18(1):9. doi: 10.1186/s12877-018-0704-8.

32.

Associations between the Drug Burden Index, Potentially Inappropriate Medications and Quality of Life in Residential Aged Care.

Harrison SL, Kouladjian O'Donnell L, Bradley CE, Milte R, Dyer SM, Gnanamanickam ES, Liu E, Hilmer SN, Crotty M.

Drugs Aging. 2018 Jan;35(1):83-91. doi: 10.1007/s40266-017-0513-3.

PMID:
29322470
33.

Prevalence of Potentially Inappropriate Medication Use in Older Inpatients with and without Cognitive Impairment: A Systematic Review.

Redston MR, Hilmer SN, McLachlan AJ, Clough AJ, Gnjidic D.

J Alzheimers Dis. 2018;61(4):1639-1652. doi: 10.3233/JAD-170842.

PMID:
29278890
34.

Drug Burden and its Association with Falls Among Older Adults in New Zealand: A National Population Cross-Sectional Study.

Jamieson HA, Nishtala PS, Scrase R, Deely JM, Abey-Nesbit R, Connolly MJ, Hilmer SN, Abernethy DR, Schluter PJ.

Drugs Aging. 2018 Jan;35(1):73-81. doi: 10.1007/s40266-017-0511-5.

PMID:
29222667
35.

A population-level study examining discontinuation of statins in older people with dementia.

Narayan SW, Hilmer SN, Nishtala PS.

Eur J Clin Pharmacol. 2018 Mar;74(3):379-381. doi: 10.1007/s00228-017-2390-4. Epub 2017 Dec 1. No abstract available.

PMID:
29192380
36.

Ascertainment of self-reported prescription medication use compared with pharmaceutical claims data.

Gnjidic D, Du W, Pearson SA, Hilmer SN, Banks E.

Public Health Res Pract. 2017 Oct 11;27(4). pii: 27341702. doi: 10.17061/phrp27341702.

37.

Prescribing for frail older people.

Hilmer SN, Gnjidic D.

Aust Prescr. 2017 Oct;40(5):174-178. doi: 10.18773/austprescr.2017.055. Epub 2017 Oct 3. Review. No abstract available.

38.

A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.

Reeve E, Moriarty F, Nahas R, Turner JP, Kouladjian O'Donnell L, Hilmer SN.

Expert Opin Drug Saf. 2018 Jan;17(1):39-49. doi: 10.1080/14740338.2018.1397625. Epub 2017 Nov 6. Review.

PMID:
29072544
39.

N-of-1 trials for assessing the effects of deprescribing medications on short-term clinical outcomes in older adults: a systematic review.

Clough AJ, Hilmer SN, Naismith SL, Kardell LD, Gnjidic D.

J Clin Epidemiol. 2018 Jan;93:112-119. doi: 10.1016/j.jclinepi.2017.09.015. Epub 2017 Sep 22. Review.

PMID:
28951110
40.

A Comparison of Two Mouse Frailty Assessment Tools.

Kane AE, Huizer-Pajkos A, Mach J, Mitchell SJ, de Cabo R, Le Couteur DG, Howlett SE, Hilmer SN.

J Gerontol A Biol Sci Med Sci. 2017 Jul 1;72(7):904-909. doi: 10.1093/gerona/glx009.

41.

Pharmacokinetic and pharmacodynamic alterations in older people with dementia.

Reeve E, Trenaman SC, Rockwood K, Hilmer SN.

Expert Opin Drug Metab Toxicol. 2017 Jun;13(6):651-668. doi: 10.1080/17425255.2017.1325873. Epub 2017 May 10. Review.

PMID:
28460576
42.

The impact of frailty on coagulation and responses to warfarin in acute older hospitalised patients with atrial fibrillation: a pilot study.

Nguyen TN, Morel-Kopp MC, Pepperell D, Cumming RG, Hilmer SN, Ward CM.

Aging Clin Exp Res. 2017 Dec;29(6):1129-1138. doi: 10.1007/s40520-017-0733-8. Epub 2017 Mar 2.

PMID:
28255906
43.

Medicine information exchange networks among healthcare professionals and prescribing in geriatric medicine wards.

Chan B, Reeve E, Matthews S, Carroll PR, Long JC, Held F, Latt M, Naganathan V, Caplan GA, Hilmer SN.

Br J Clin Pharmacol. 2017 Jun;83(6):1185-1196. doi: 10.1111/bcp.13222. Epub 2017 Feb 1.

44.

The association between benzodiazepine use and sleep quality in residential aged care facilities: a cross-sectional study.

Chen L, Bell JS, Visvanathan R, Hilmer SN, Emery T, Robson L, Hughes JM, Tan EC.

BMC Geriatr. 2016 Nov 26;16(1):196.

45.

Animal models of frailty: current applications in clinical research.

Kane AE, Hilmer SN, Mach J, Mitchell SJ, de Cabo R, Howlett SE.

Clin Interv Aging. 2016 Oct 26;11:1519-1529. eCollection 2016. Review.

46.
47.

Atrial fibrillation, anticoagulant stroke prophylaxis and bleeding risk with ibrutinib therapy for chronic lymphocytic leukaemia and lymphoproliferative disorders.

Mulligan SP, Ward CM, Whalley D, Hilmer SN.

Br J Haematol. 2016 Nov;175(3):359-364. doi: 10.1111/bjh.14321. Epub 2016 Sep 9. No abstract available.

PMID:
27611114
48.

Development, validation and evaluation of an electronic pharmacological tool: The Drug Burden Index Calculator©.

Kouladjian L, Gnjidic D, Chen TF, Hilmer SN.

Res Social Adm Pharm. 2016 Nov - Dec;12(6):865-875. doi: 10.1016/j.sapharm.2015.11.002. Epub 2015 Nov 11.

PMID:
26655397
49.

Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study.

Jamsen KM, Gnjidic D, Hilmer SN, Ilomäki J, Le Couteur DG, Blyth FM, Handelsman DJ, Naganathan V, Waite LM, Cumming RG, Bell JS.

Ann Med. 2017 Mar;49(2):157-164. doi: 10.1080/07853890.2016.1252053. Epub 2016 Nov 18.

PMID:
27763767

Supplemental Content

Loading ...
Support Center